Cardiovascular mortality in children and young adults with end-stage kidney disease

被引:331
作者
Parekh, RS
Carroll, CE
Wolfe, RA
Port, FK
机构
[1] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Dept Internal Med, Baltimore, MD 21218 USA
[3] Univ Chicago, Natl Opin Res Ctr, Chicago, IL 60637 USA
[4] Univ Michigan, Kidney & Epidemiol & Cost Ctr, Dept Epidemiol, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Kidney & Epidemiol & Cost Ctr, Dept Biostat, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Kidney & Epidemiol & Cost Ctr, Dept Med, Ann Arbor, MI 48109 USA
关键词
D O I
10.1067/mpd.2002.125910
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To analyze cardiovascular death in a national end-stage renal disease (ESRD) population. Study design: This retrospective, observational study with data from the US Renal Data Systems analyzed 1380 deaths from 1990 to 1996 among patients who started ESRD therapy as children and died before 30 years of age. Results: Percentage of cardiac deaths (n = 311) varied by age and was higher among black patients (0-4 years, 36%; 5-9 years, 18%; 10-14 years, 35%; 15-19 years, 22%; 20-30 years, 32%) than white patients (18%, 12%, 17%, 14%, and 23%, respectively). Among black patients, cardiac deaths occurred in 11% of transplant recipients, 34% of dialysis patients, and among white patients 9% and 25%, respectively. Black patients were 1.6 times more likely to die of a cardiac death (P < .001) than white patients. Transplant recipients had 78% lower risk of cardiac death than dialysis patients (odds ratio = 0.22; P = .0001). The cardiac death rate among dialysis patients was 21.4 per 1000 patient-years in black patients compared with 20.5 in white patients. Transplantation cardiac death rates were lower in black patients, 2.1 per 1000 patient-years, and 1.3 in white patients. Conclusions: Cardiovascular death accounts for 23% of pediatric and young adult ESRD deaths. Black patients and dialysis patients are at higher risk of a cardiac death compared with white patients and transplant recipients. Further studies are needed to identify risk factors associated with cardiovascular death in patients with ESRD.
引用
收藏
页码:191 / 197
页数:7
相关论文
共 22 条
[1]  
[Anonymous], NATL VITAL STAT REPO
[2]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119
[3]   Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease [J].
Foley, RN ;
Parfrey, PS ;
Harnett, JD ;
Kent, GM ;
Murray, DC ;
Barre, PE .
KIDNEY INTERNATIONAL, 1996, 49 (05) :1379-1385
[4]   Cardiovascular risk factors, comorbidity, and survival outcomes in black and white dialysis patients [J].
Furth, S ;
Hermann, JA ;
Powe, NR .
SEMINARS IN DIALYSIS, 1998, 11 (02) :102-105
[5]  
ISLAM S, 1994, PEDIATRICS, V94, P494
[6]   Left ventricular abnormalities in children, adolescents and young adults with renal disease [J].
Johnstone, LM ;
Jones, CL ;
Grigg, LE ;
Wilkinson, JL ;
Walker, RG ;
Powell, HR .
KIDNEY INTERNATIONAL, 1996, 50 (03) :998-1006
[7]   Effect of enteral feeding on lipid subfractions in children with chronic renal failure [J].
Kari, JA ;
Shaw, V ;
Vallance, DT ;
Rees, L .
PEDIATRIC NEPHROLOGY, 1998, 12 (05) :401-404
[8]   Plasma lipoproteins in patients with chronic renal failure (CRF) [J].
Kimak E. ;
Solski J. ;
Janicka L. ;
Duma D. ;
Zagojska M. .
International Urology and Nephrology, 1997, 29 (5) :597-601
[9]   Correlates of lipoprotein(a) levels in a biracial cohort of young girls: The NHLBI Growth and Health Study [J].
Kimm, SYS ;
Pasagian-Macaulay, A ;
Aston, CE ;
McAllister, AE ;
Glynn, NW ;
Kamboh, MI ;
Ferrell, RE .
JOURNAL OF PEDIATRICS, 1999, 135 (02) :169-176
[10]   Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start? [J].
Levey, AS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S5-S13